ASSESSING THE POTENTIAL VALUE OF AN INNOVATIVE ONCOLOGY THERAPY FROM THE HEALTH TECHNOLOGY ASSESSMENT (HTA) PERSPECTIVE: MARRYING CLINICAL VALUE FRAMEWORKS WITH ECONOMIC ASSESSMENT METHODOLOGY

被引：0
|
作者：
Zheng, Y. [1 ]
Lanitis, T. [2 ]
Ambavane, A. [2 ]
Proskorovsky, I [3 ]
Bharmal, M. [4 ]
Phatak, H. [1 ]
机构：
[1] EMD Serono Inc, Rockland, MA USA
[2] Evidera, London, England
[3] Evidera, St Laurent, PQ, Canada
[4] Merck KGaA, Darmstadt, Germany
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.108
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN26
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [41] Threats to the value of Health Technology Assessment: Qualitative evidence from Canada and Poland
    Wranik, Wieslawa Dominika
    Zielinska, Dorota Anna
    Gambold, Lies
    Sevgur, Serperi
    HEALTH POLICY, 2019, 123 (02) : 191 - 202
  • [42] Threats to the Value of Health Technology Assessment: Qualitative Evidence From Canada and Poland
    Wranik, Wieslawa Dominika
    Gambold, Liesl
    Zielinska, Dorota
    Sevgur, Serperi
    INTERNATIONAL JOURNAL OF QUALITATIVE METHODS, 2019, 18
  • [43] Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop
    Al-Omar, Hussain A.
    Aljuffali, Ibrahim A.
    Sola-Morales, Oriol
    SAUDI PHARMACEUTICAL JOURNAL, 2021, 29 (09) : 946 - 954
  • [44] VALUE ASSESSMENT OF PROPORTIONAL HAZARDS TESTINGS IN ONCOLOGY HTA SUBMISSIONS FOR PD-1/PD-L1 INHIBITORS - A NICE PERSPECTIVE
    Sharma, S.
    Singh, B.
    Mangat, G.
    Siddiqui, M. K.
    VALUE IN HEALTH, 2020, 23 : S70 - S70
  • [45] Assessment of Value Using the American Society of Clinical Oncology (ASCO) and European Society of Medical Oncology (ESMO) Frameworks for Novel Therapies for the Hematologic Malignancies
    Cheung, Matthew C.
    Cheng, Sierra
    McDonald, Erica
    Arciero, Vanessa
    Qureshi, Mahin
    Chan, Kelvin
    BLOOD, 2016, 128 (22)
  • [46] CHARACTERISTICS OF DATA SOURCES AND INPUTS USED IN VALUE AND HEALTH TECHNOLOGY ASSESSMENT ECONOMIC EVALUATIONS: A PILOT ANALYSIS
    Desai, B.
    Gressler, L.
    Mattingly, T. J.
    Perfetto, E. M.
    VALUE IN HEALTH, 2022, 25 (07) : S509 - S509
  • [47] THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) NET HEALTH BENEFIT (NHB) ASSESSMENT TOOL: WHICH IMPLICATIONS FOR VALUE ASSESSMENT OF CANCER THERAPIES?
    Remuzat, C.
    Chouaid, C.
    Auquier, P.
    Borget, I
    Kornfeld, M.
    Toumi, M.
    VALUE IN HEALTH, 2016, 19 (07) : A359 - A360
  • [48] Mavacamten for hypertrophic cardiomyopathy: effectiveness and value A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum
    Beinfeld, Molly
    Wasfy, Jason H.
    Walton, Surrey
    Sarker, Jyotirmoy
    Nhan, Emily
    Rind, David M.
    Pearson, Steven D.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (03): : 369 - 375
  • [49] Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil
    Biglia, Luiza Vasconcelos
    Felippini, Arturo
    Ribeiro, Tatiane Bomfim
    Lima, Tacio de Mendonca
    Aguiar, Patricia Melo
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2025, 41 (01)
  • [50] Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective
    Macaulay, Richard
    Ahuja, Amit
    Ademisoye, Ebenezer
    Juarez-Garcia, Ariadna
    Shaw, James W.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2019, 11 : 199 - 219
12345